Laurion Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Laurion Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-99,000	Closed	-$2.69M	–	1270
2020 Q1	$2.69M	Sell	99,000 -30,500	-24%	-$849K	0.03%	314
2019 Q4	$2.56M	Buy	+129,500	New	+$2.07M	0.02%	421
2019 Q3	–	Sell	-25,903	Closed	-$322K	–	1379
2019 Q2	$322K	Buy	+25,903	New	+$344K	﹤0.01%	769
2019 Q1	–	Sell	-226,815	Closed	-$2.5M	–	1438
2018 Q4	$2.5M	Buy	+226,815	New	+$3.16M	0.04%	411
2018 Q3	–	Sell	-13,910	Closed	-$284K	–	1668
2018 Q2	$284K	Buy	+13,910	New	+$298K	﹤0.01%	1104
2016 Q3	–	Sell	-18,000	Closed	-$194K	–	1167
2016 Q2	$194K	Buy	+18,000	New	+$186K	﹤0.01%	753

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Laurion Capital Management's MNTA Position: Q2 2020 in Review

Laurion Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 99,000 shares — an estimated $2.69M sold.

Laurion Capital Management first reported a position in MNTA in Q2 2016 and held it in 6 quarters. The position peaked at $2.69M in Q1 2020. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

Laurion Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Laurion Capital Management sold 99,000 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $2.69M.
Laurion Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 6 quarters.
Laurion Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $2.69M in Q1 2020.
237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.